Use of nonsteroidal anti-inflammatory drugs predicts improved patient survival for PIK3CA-altered head and neck cancer.
The Journal Of Experimental Medicine
Hedberg, Matthew L ML; Peyser, Noah D ND; Bauman, Julie E JE; Gooding, William E WE; Li, Hua H; Bhola, Neil E NE; Zhu, Tian Ran TR; Zeng, Yan Y; Brand, Toni M TM; Kim, Mi-Ok MO; Jordan, Richard C K RCK; VandenBerg, Scott S; Olivas, Victor V; Bivona, Trever G TG; Chiosea, Simion I SI; Wang, Lin L; Mills, Gordon B GB; Johnson, Jonas T JT; Duvvuri, Umamaheswar U; Ferris, Robert L RL; Ha, Patrick P; Johnson, Daniel E DE; Grandis, Jennifer R JR